VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > GranhamF the Vultur Back to 0.1099 (15 cents) on the US side

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Oct 15, 2024 2:54pm

81 Views

Post# 36266831

RE:GranhamF the Vultur Back to 0.1099 (15 cents) on the US side

jopatclo wrote:
Remember Hugh MacNaught “As more hospitals look to Ventripoint to provide advanced whole-heart analysis, this MDR submission is an important next step in the development and commercialization of the VMS+ family of devices” said Ventripoint President and CEO, Hugh MacNaught. “Upon approval we will be able to provide European cardiologists and care providers with one of the simplest, most-advanced, non-invasive heart-imaging tools available.” and on post Dr.Adams

4. The Company has a license to sell VMS+4.0 in Canada and now it has submitted all the information needed for approval for Europe. Our previous submissions for VMS+1.0, 2.0 and 3.0 were approved fairly quickly in about 6-8 weeks and so if this holds for this submission, we should have approval November. We will see.

5. We continue to support the basic VMS+3.0 and upgrade users to the advanced VMS+3.2, while we wait for approvals for the premium VMS+4.0.

6. We recently upgraded Seattle Children’s Hopsital to VMS+3.2 and you can watch Dr, Soriano speak about his experiences on a new video on our website (https://youtu.be/Ucu6uGRMtEs+) from the Take Heart conference.

now 0.165$ big volume 683,500
I think Jeffrey Soble of Ascend cardiovascular and Beth Rumack, Chief Operating Officer Ollie Hinkle Heart Foundation FDA V4.0 and Sales at any time now Insiders know! more than the negatives that denigrate ventripoint. -“We want to introduce Ventripoint to all our hospital partners, to make it a standard of care,” Beth Rumack, Chief Operating Officer Ollie Hinkle Heart Foundation and now (The Ollie Hinkle Foundation posted videos of their Take Heart 2024 conference on YouTube. In the first session Dr. Soriano of Seattle Children's Hospital provides a very nice overview of VMS+ and its benefits to patients and care providers. Take Heart 2024: Session 1 youtube.com https://www.youtube.com/watch?app=desktop&v=Ucu6uGRMtEs ) -“Our aim is that by working together, we can ultimately provide reliable and effective tools for clinicians on a global scale.” Jeffrey Soble, MD CEO ASCEND (and now and now The BEST Automation and Analytics on PLANET GEN3EHO On Ascend's website https://ascendcv.com/ ) #vpt,

V:VPT - VentriPoint Diagnostics Ltd. - https://www.ventripoint.com

14:46:17 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
VPT - V	12.0	0.16	·	0.165	51.5	0.165	+0.01	6.5	683.5	99	172	0.155 0.165 0.15	0.36 0.135	14:20:12	08:11	15 min RT 2¢
TSX-V - V	12.0	0.16	·	0.165	51.5	0.16	+0.005	3.2	256.3	38	44	0.155 0.16 0.15	0.36 0.135	14:01:21		15 min
NEO ATS - U						0.16	+0.005	3.2	21.9	3	16	0.15 0.16 0.15		11:30:02		15 min
Alpha - A						0.165	+0.01	6.5	58.5	9	6	0.15 0.165 0.15		14:20:12		15 min
Omega - O						0.165	+0.01	6.5	212.0	30	49	0.15 0.165 0.15		13:59:39		15 min
Pure - P						0.155			0.6		3			Oct 03		15 min
Chi-X - X						0.16	+0.005	3.2	9.5	1	4	0.16 0.16 0.16		13:07:43		15 min
CX2 - H						0.16	+0.005	3.2	121.5	17	41	0.15 0.165 0.15		13:16:59		15 min
CXD - D						0.15	-0.005	-3.2	2.0	0	2	0.15 0.15 0.15		09:35:54		15 min
TriAct - M						0.155			1.2		7			Dec 05-19		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 172

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
14:20:12	A	0.165	0.01	500	7 TD Sec	79 CIBC	K
14:20:12	U	0.165	0.01	400	7 TD Sec	2 RBC	E
14:01:21	V	0.16	0.005	5,000	7 TD Sec	19 Desjardins	K
13:59:39	O	0.165	0.01	500	19 Desjardins	1 Anonymous	K
13:43:56	P	0.16	0.005	250	5 Citadel	19 Desjardins	E
13:16:59	O	0.16	0.005	5,500	1 Anonymous	1 Anonymous	K
13:16:59	H	0.16	0.005	6,000	1 Anonymous	85 Scotia	K
13:16:59	V	0.16	0.005	28,500	7 TD Sec	85 Scotia	K
13:13:54	O	0.165	0.01	500	19 Desjardins	1 Anonymous	K
13:11:18	H	0.16	0.005	1,000	1 Anonymous	80 National Bank	K